30 years of historical data (1996–2025) · Healthcare · Medical - Distribution
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Henry Schein, Inc. trades at 22.2x earnings, roughly in line with its 5-year average of 21.6x, sitting at the 74th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x. On a free-cash-flow basis, the stock trades at 14.5x P/FCF, 25% below the 5-year average of 19.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $8.3B | $9.3B | $9.0B | $10.0B | $11.0B | $11.0B | $9.6B | $10.0B | $9.5B | $8.7B | $9.7B |
| Enterprise Value | $11.8B | $12.8B | $11.7B | $12.5B | $12.4B | $12.1B | $10.2B | $10.9B | $11.3B | $10.2B | $10.8B |
| P/E Ratio → | 22.15 | 23.28 | 23.09 | 23.96 | 20.43 | 17.42 | 23.88 | 19.62 | 17.65 | 21.33 | 19.07 |
| P/S Ratio | 0.63 | 0.70 | 0.71 | 0.81 | 0.87 | 0.89 | 0.95 | 1.00 | 0.72 | 0.70 | 0.83 |
| P/B Ratio | 1.84 | 1.93 | 1.86 | 1.94 | 2.36 | 2.35 | 2.22 | 2.54 | 2.46 | 2.37 | 2.83 |
| P/FCF | 14.51 | 16.17 | 13.61 | 28.26 | 21.74 | 17.43 | 17.43 | 17.23 | 15.93 | 18.69 | 17.72 |
| P/OCF | 11.67 | 13.01 | 10.61 | 19.95 | 18.28 | 15.49 | 16.01 | 15.22 | 13.82 | 15.90 | 15.70 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Henry Schein, Inc.'s enterprise value stands at 11.1x EBITDA, 5% below its 5-year average of 11.7x. The Healthcare sector median is 14.1x, placing the stock at a 22% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.97 | 0.93 | 1.02 | 0.98 | 0.97 | 1.00 | 1.09 | 0.86 | 0.82 | 0.93 |
| EV / EBITDA | 11.08 | 11.97 | 11.45 | 13.04 | 10.77 | 11.36 | 13.51 | 11.82 | 13.56 | 9.61 | 10.96 |
| EV / EBIT | 15.62 | 18.41 | 18.24 | 19.94 | 16.19 | 14.09 | 18.79 | 14.84 | 18.52 | 11.59 | 13.73 |
| EV / FCF | — | 22.33 | 17.77 | 35.54 | 24.47 | 19.17 | 18.49 | 18.78 | 19.10 | 21.90 | 19.84 |
Margins and return-on-capital ratios measuring operating efficiency
Henry Schein, Inc. earns an operating margin of 5.7%. ROE of 8.3% is modest. ROIC of 7.1% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.1% | 29.1% | 29.7% | 29.6% | 28.9% | 29.6% | 27.8% | 31.0% | 22.0% | 27.3% | 27.9% |
| Operating Margin | 5.7% | 5.7% | 5.8% | 5.8% | 7.4% | 6.9% | 5.6% | 7.3% | 5.3% | 6.9% | 7.1% |
| Net Profit Margin | 3.0% | 3.0% | 3.1% | 3.4% | 4.3% | 5.0% | 4.0% | 5.1% | 4.1% | 3.3% | 4.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.3% | 8.3% | 7.8% | 8.5% | 11.5% | 13.9% | 9.8% | 13.1% | 14.3% | 11.5% | 14.8% |
| ROA | 3.7% | 3.7% | 3.8% | 4.3% | 6.3% | 7.7% | 5.4% | 6.5% | 6.5% | 5.6% | 7.6% |
| ROIC | 7.1% | 7.1% | 7.1% | 7.8% | 11.9% | 12.0% | 8.8% | 10.4% | 9.6% | 13.4% | 14.0% |
| ROCE | 9.8% | 9.8% | 9.5% | 10.0% | 14.9% | 14.7% | 10.7% | 14.1% | 13.4% | 18.3% | 18.6% |
Solvency and debt-coverage ratios — lower is generally safer
Henry Schein, Inc. carries a Debt/EBITDA ratio of 3.4x, which is moderately leveraged (6% above the sector average of 3.3x). Net debt stands at $3.5B ($3.7B total debt minus $156M cash). Interest coverage of 4.6x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 0.77 | 0.59 | 0.53 | 0.32 | 0.26 | 0.23 | 0.25 | 0.50 | 0.46 | 0.36 |
| Debt / EBITDA | 3.45 | 3.45 | 2.80 | 2.85 | 1.30 | 1.14 | 1.33 | 1.09 | 2.32 | 1.58 | 1.23 |
| Net Debt / Equity | — | 0.74 | 0.57 | 0.50 | 0.30 | 0.24 | 0.13 | 0.23 | 0.49 | 0.41 | 0.34 |
| Net Debt / EBITDA | 3.30 | 3.30 | 2.68 | 2.67 | 1.20 | 1.03 | 0.77 | 0.97 | 2.25 | 1.41 | 1.17 |
| Debt / FCF | — | 6.16 | 4.16 | 7.28 | 2.73 | 1.74 | 1.06 | 1.54 | 3.17 | 3.21 | 2.12 |
| Interest Coverage | 4.63 | 4.63 | 4.92 | 7.23 | 17.39 | 31.09 | 13.08 | 14.39 | 8.06 | 16.34 | 24.70 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.38x means Henry Schein, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.76x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.67x to 1.38x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | 1.38 | 1.42 | 1.67 | 1.79 | 1.67 | 1.66 | 1.58 | 1.30 | 1.44 | 1.44 |
| Quick Ratio | 0.76 | 0.76 | 0.78 | 1.00 | 0.91 | 0.86 | 1.00 | 0.88 | 0.86 | 0.76 | 0.72 |
| Cash Ratio | 0.05 | 0.05 | 0.04 | 0.06 | 0.05 | 0.05 | 0.18 | 0.05 | 0.02 | 0.06 | 0.03 |
| Asset Turnover | — | 1.18 | 1.24 | 1.17 | 1.47 | 1.46 | 1.30 | 1.40 | 1.55 | 1.58 | 1.71 |
| Inventory Turnover | 4.67 | 4.67 | 4.92 | 4.79 | 4.58 | 4.69 | 4.83 | 4.83 | 4.60 | 4.69 | 5.01 |
| Days Sales Outstanding | — | 45.71 | 42.68 | 55.11 | 41.62 | 42.74 | 51.39 | 45.55 | 32.31 | 44.60 | 39.56 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Henry Schein, Inc. returns 10.2% to shareholders annually primarily through share buybacks. The earnings yield of 4.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.5% | 4.3% | 4.3% | 4.2% | 4.9% | 5.7% | 4.2% | 5.1% | 5.7% | 4.7% | 5.2% |
| FCF Yield | 6.9% | 6.2% | 7.3% | 3.5% | 4.6% | 5.7% | 5.7% | 5.8% | 6.3% | 5.4% | 5.6% |
| Buyback Yield | 10.2% | 9.2% | 4.3% | 2.8% | 4.4% | 3.6% | 0.9% | 5.3% | 2.1% | 5.2% | 5.7% |
| Total Shareholder Yield | 10.2% | 9.2% | 4.3% | 2.8% | 4.4% | 3.6% | 0.9% | 5.3% | 2.1% | 5.2% | 5.7% |
| Shares Outstanding | — | $122M | $128M | $132M | $138M | $142M | $143M | $149M | $154M | $158M | $162M |
Compare HSIC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $8B | 22.2 | 11.1 | 14.5 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 | |
| $3B | 33.9 | 17.4 | 52.2 | 31.5% | 8.8% | 19.2% | 21.6% | 0.6 | |
| $171M | -0.2 | 1.7 | — | — | 1.0% | -2111.6% | 1.8% | 2.6 | |
| $91B | 28.9 | 18.5 | 17.4 | 3.5% | 1.2% | — | 540.6% | 1.5 | |
| $45B | 29.7 | 16.5 | 24.4 | 3.7% | 1.0% | — | 3378.7% | 3.0 | |
| $2B | -3.7 | 7.2 | 21.5 | 50.0% | 6.8% | -36.4% | 5.1% | 4.1 | |
| $12B | 30.8 | 14.4 | 25.4 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 | |
| $5B | 96.6 | 14.6 | 19.5 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 | |
| $63M | -1.1 | — | — | 32.8% | -8.9% | -72.8% | -51.3% | — | |
| $12B | 22.8 | 19.4 | 20.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 | |
| $112B | 34.8 | 20.2 | 26.1 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs DXP Enterprises, Inc..
Start ComparisonQuick answers to the most common questions about buying HSIC stock.
Henry Schein, Inc.'s current P/E ratio is 22.2x. The historical average is 21.3x. This places it at the 74th percentile of its historical range.
Henry Schein, Inc.'s current EV/EBITDA is 11.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.
Henry Schein, Inc.'s return on equity (ROE) is 8.3%. The historical average is 11.6%.
Based on historical data, Henry Schein, Inc. is trading at a P/E of 22.2x. This is at the 74th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Henry Schein, Inc. has 29.1% gross margin and 5.7% operating margin.
Henry Schein, Inc.'s Debt/EBITDA ratio is 3.4x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.